Sun Strikes Deal For Clascoterone In US And Canada

Enters Into License And Supply Agreement With Italy’s Cassiopea For Winlevi

Sun Pharma has expanded its dermatology portfolio by entering into a partnership with Italy’ Cassiopea to market Winlevi (clascoterone) 1% cream in the US and Canada, and expects to make it available in the US inthe fourth quarter of 2021.

US Canada
Sun pharma will introduce clascoterone cream in the US and Canada by the fourth quarter of 2021 • Source: Alamy

Sun Pharmaceutical Industries Ltd. has announced entering into a license and supply agreement with Italy’s Cassiopea S.p.A. that will give the Indian company rights to market Winlevi (clascoterone) 1% cream in the US and Canada. The companies expect to make Winlevi available in the US in the fourth quarter of 2021.

Commenting on the partnership, Abhay Gandhi, CEO, North America of Sun Pharma, said the company was “pleased to enter into...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business